awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39032812-3E0283F3-92BD-4C98-B71D-8BBACC9BE491
Q39032812-3E0283F3-92BD-4C98-B71D-8BBACC9BE491
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39032812-3E0283F3-92BD-4C98-B71D-8BBACC9BE491
Harnessing benefit from targeting tumor associated carbohydrate antigens.
P2860
Q39032812-3E0283F3-92BD-4C98-B71D-8BBACC9BE491
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39032812-3E0283F3-92BD-4C98-B71D-8BBACC9BE491
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7cd94f998411fb4f2b70f93c4039d5f9c7f11d99
P2860
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study.